Dr. Christoph Heusser, Head of Immunology, is an immunology expert who pioneered antibody-based therapies and antibody-mediated effector functions. He was Head of Immunology at Ciba-Geigy and Head of the Transplantation- Immunology Unit at Novartis and gave lectures on antibody-based interventions at the University Basel for 15 years.

Michel Petignat, Head of Human Resources, is a qualified HR Specialist in the Life Sciences industry. During his long and outstanding professional career, Michel worked as an HR Manager in leading pharma and biotech companies such as Sandoz, Novartis Pharma, Syngenta Crop Protection and Actelion Pharmaceuticals.

Dr. Bernhard Hostettler, Head of Intellectual Property, originally is an organic chemist. After his Ph.D. at ETH Zürich, Bernhard was active in research for more than 20 years with companies Roche, CIBA, Syngenta and Givaudan.

David Allman is a biochemist by training and has over 25 years of global experience in the pharmaceutical industry having worked for pharmaceutical companies and leading clinical research organizations as well as applying his expertise in the virtual development arena.

Dr. Robert Ettlin is the Head of Preclinical Safety in Swiss Rockets. After some years in toxicological pathology at F. Hoffmann La Roche Ltd., Ettlin joined Sandoz Ltd. in Basel, where he advanced to Head of Toxicology and later Head of Development Operations Switzerland.

Dr. Zoltan Sümeghy holds a Ph.D. in Biochemistry from the Technical University of Budapest, where he previously studied Biochemical Engineering. Dr. Sümeghy started his career as a Lab Head at the Biotechnology Research Department, where he was responsible for USP development for all cell culture projects including scale-up, as well as for establishing the first development and GMP facility for cell cultures at Sandoz.

Albert Muntane Casanova is an accomplished manager responsible for overseeing the financial activities of the company.